N
Neal Zimbaldi
Researcher at University of Texas at Austin
Publications - 10
Citations - 500
Neal Zimbaldi is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Low sodium & Weight loss. The author has an hindex of 8, co-authored 10 publications receiving 496 citations. Previous affiliations of Neal Zimbaldi include University of Mississippi Medical Center & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Reduction in Long-term Antihypertensive Medication Requirements: Effects of Weight Reduction by Dietary Intervention in Overweight Persons With Mild Hypertension
Barry R. Davis,M. Donald Blaufox,Albert Oberman,Sylvia Wassertheil-Smoller,Neal Zimbaldi,Jeffrey A. Cutler,Kent Kirchner,Herbert G. Langford +7 more
TL;DR: It is demonstrated that weight reduction is an effective long-term therapy for maintaining blood pressure in the normal range when used as monotherapy or in combination with either thiazide diuretics or beta-blockers.
Journal ArticleDOI
Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group.
Herbert G. Langford,Barry R. Davis,Donald Blaufox,A. Oberman,S. Wassertheil-Smoller,Morton Hawkins,Neal Zimbaldi +6 more
TL;DR: The Trial of Antihypertensive Interventions and Management is a multicenter randomized trial designed to examine the diastolic blood pressure response of various combinations of pharmacological and dietary interventions in the treatment of mild hypertension and found drugs outperform diet, and weight loss is beneficial, especially with diuretics.
Journal ArticleDOI
Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status.
Albert Oberman,Sylvia Wassertheil-Smoller,Herbert G. Langford,M. Donald Blaufox,Barry R. Davis,Thomas P. Blaszkowski,Neal Zimbaldi,C. Morton Hawkins +7 more
TL;DR: Mild hypertension was generally reduced to desirable levels within 6 months by monotherapy and a differential effect on overall cardiovascular risk depending on the diet and drug used was indicated.
Journal ArticleDOI
Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group.
Barry R. Davis,A. Oberman,M.D. Blaufox,S Wassertheil-Smoller,C.M. Hawkins,J A Cutler,Neal Zimbaldi,H.G. Langford +7 more
TL;DR: It is suggested that the antihypertensive drug prescribed affects the success of a conjoint weight loss program and speculated that the difference between the drugs may be due to their intrinsic effects on the sympathetic nervous system and related metabolic changes.
Journal ArticleDOI
Trial of antihypertensive intervention and management: Greater efficacy with weight reduction than with a sodium-potassium intervention
Judith Wylie-Rosett,Sylvia Wassertheil-Smoller,M. Donald Blaufox,Barry R. Davis,Herbert G. Langford,Albert Oberman,Stephanie Jennings,Heidi Hataway,Judith Stern,Neal Zimbaldi +9 more
TL;DR: Analysis of 3-day food records indicated that sodium intake decreased from 141.1 to 85.8 mmol and potassium intake increased from 76.4 to 90.5 mmol, indicating that the goal for weight reduction was more easily achieved than thegoal for electrolyte modification.